RVPHealthcare · Medical Instruments & Supplies

RVP Stock Forecast: Retractable Technologies, Inc. Price Predictions for 2026-2027

Last close, 18 Sept 2026

$0.72

+2.76% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 60 of 100 as at 19 Sept 2026 — in the upper half.

Market cap

$21.6M

Ticker Nerd rank

60 / 100

Median analyst target

—

Analysts covering

Revenue$7.2M−31.1% y/y

Operating income−$3.7M

Net income$2.8M

Free cash flow−$1.8M

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

+5.8%

−0.1%

YTD

−6.6%

−13.3%

From 52W high

−32.1%

From 52W low

+16.0%

$0.62

$1.06

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

RVP stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Retractable Technologies, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026

60 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility

Size

Growth

Issuance

Accruals

Momentum

Quality

Revisions

Value

Volatility (96): The share price has been relatively steady.

Value (11): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

RVP stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on RVP, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. RVP appears on the weeks it earns a place.

Performance

RVP vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, Retractable Technologies, Inc. returned −13.3% against +16.3% for the S&P 500, dividends included.

RVP vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

RVP analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Retractable Technologies, Inc. (RVP) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 8.1×
Price / sales: 0.6×
Price / book: 0.3×
EV / EBITDA: 1.2×

Growth & margins

Revenue growth (YoY): −31.1%
Earnings growth (YoY): —
Gross margin: 2.7%
Operating margin: −71.5%
Net margin: −9.9%

Returns & dividend

Return on equity: −4.5%
Return on assets: −9.4%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Retractable Technologies, Inc. (RVP) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Retractable Technologies, Inc. has a market value of $21.6M and an enterprise value of −$17.1M.
Revenue in the twelve months to 30 June 2026: $33.9M. The latest quarter shrank 31.1% year on year.
Net income over the same four quarters: −$3.4M, a −9.9% net margin.
Free cash flow in the twelve months to 30 June 2026: −$5.1M.
Retractable Technologies, Inc. spent $230K on dividends in the twelve months to 30 June 2026.
Shares outstanding: 29.9M.
Trailing P/E: 8.1×.
Retractable Technologies, Inc. employs 195 people — $174K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Sept 2026

Data provided by Twelve Data

Peers

RVP vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies

Company	Market cap	TKN rank
RVPRetractable Technologies, Inc.	$21.6M	60
FEMYFemasys, Inc.	$21.7M	43
BNGOBionano Genomics, Inc.	$20.4M	78
HBIOHarvard Bioscience, Inc.	$35.6M	98
MLSSMilestone Scientific, Inc.	$35.9M	85
RGNTRegentis Biomaterials Ltd.	$12.7M	8
NEPHNephros, Inc.	$45.8M	93

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Retractable Technologies, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest RVP news & analysis

Retractable Technologies, Inc. Supports Senator Blackburn's ONSHORE Manufacturing Act

Business Wire · 3 Sept 2026positive

Retractable Technologies, Inc. announced its support for Senator Marsha Blackburn's ONSHORE Manufacturing Act, legislation that would provide tax incentives for U.S. manufacturing of critical medical supplies, including investments in advanced manufacturing equipment and facility modernization.

Why it matters — As a domestic medical device manufacturer, RVP could benefit from legislation that promotes and incentivizes U.S.-based production of critical medical supplies.

RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes

Zacks Investment Research · 20 Aug 2026negative

Retractable Technologies reported second-quarter 2026 results in which sales weakened due to EasyPoint order timing, while investment gains drove earnings. Tariffs remain a key sourcing challenge for the company.

Why it matters — RVP watchers would care because the quarter reflects softer sales and unit volumes offset by investment gains, with tariffs posing an ongoing sourcing challenge.

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Business Wire · 14 Aug 2026negative

Retractable Technologies reported total net sales of $7.2 million for Q2 2026 and an operating loss of $5.1 million, compared to net sales of $10.4 million and the same operating loss of $5.1 million in Q2 2025. For the first half of 2026, net sales were $14.4 million with operating losses of $11.3 million versus net revenues of $18.7 million and an operating loss in the prior-year period.

Why it matters — The results show a significant decline in sales for both the quarter and first half of 2026 compared to the same periods in 2025, while operating losses persisted.

FAQ

Frequently asked questions about RVP stock

How does Ticker Nerd's model rank RVP?

As at 19 Sept 2026, Retractable Technologies, Inc. ranks 60 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (96 of 100).

What is the RVP stock forecast for 2030?

No analyst covering Retractable Technologies, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RVP are extrapolating price history, which says nothing about the business.

How has RVP stock performed over the past year?

Retractable Technologies, Inc. returned -13.3% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Retractable Technologies, Inc. do?

Retractable Technologies, Inc. is a medical device company that designs, develops, manufactures, and markets safety-engineered needle and syringe products for healthcare providers.

What is the latest news on RVP?

The most recent item we track (Business Wire, 3 Sept 2026): "Retractable Technologies, Inc. Supports Senator Blackburn's ONSHORE Manufacturing Act". Retractable Technologies, Inc. announced its support for Senator Marsha Blackburn's ONSHORE Manufacturing Act, legislation that would provide tax incentives for U.S. manufacturing of critical medical supplies, including investments in advanced manufacturing equipment and facility modernization.

Company

About Retractable Technologies, Inc.

Retractable Technologies, Inc. is a medical device company that designs, develops, manufactures, and markets safety-engineered needle and syringe products for healthcare providers. Retractable Technologies focuses on devices intended to help reduce needlestick injuries and improve handling safety in clinical settings. Its current product line includes safety syringes, insulin and tuberculin syringes, blood collection devices, IV safety catheters, retractable needles, and related accessories used in injection, specimen collection, and infusion workflows. The company serves hospitals, clinics, laboratories, and distributors across the United States and international markets. Retractable Technologies operates under brands such as VanishPoint, EasyPoint, and Patient Safe, which are recognized for their retractable and safety-focused designs. The company plays a niche role in the healthcare equipment market by supplying disposable medical products built around needle safety and contamination reduction.

CEO Mr. Thomas J. Shaw · 195 employees · United States · https://www.retractable.com